Incidence and Predictors of Maternal Cardiovascular Mortality and Severe Morbidity in the Netherlands: A Prospective Cohort Study

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Huisman, Claartje M ^a,b   Zwart, Joost J ^b,c   Roos Hesselink, Jolien W ^d   Duvekot, Johannes J ^d   van Roosmalen, Jos ^b,e  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DEVENTER HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; PRE PAR; RITODRINE; SULPROSTONE; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; AORTA DISSECTION; ARTICLE; AUTOPSY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CESAREAN SECTION; CONGENITAL HEART DISEASE; CORONARY ARTERY DISSECTION; DELIVERY; DISEASE SEVERITY; ETHNICITY; FEMALE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; INCIDENCE; INTENSIVE CARE; INTRAAORTIC BALLOON PUMP; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPLE PREGNANCY; NETHERLANDS; OBESITY; PERICARDITIS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY COMPLICATION; PROGNOSIS; RESUSCITATION; RISK FACTOR; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY; VALVULAR HEART DISEASE;

ADULT; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEART VALVE DISEASES; HUMANS; INCIDENCE; MORBIDITY; MOTHERS; MYOCARDIAL ISCHEMIA; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84874014172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056494     Document Type: Article

References (34)

1. Arafeh JM, Baird SM, (2006) Cardiac disease in pregnancy. Crit Care Nurs Q 29: 32-52.
2. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, et al. (2003) Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 52: 1-8.
3. Lewis Ge, (2007) The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers Lives: Reviewing Maternal Deaths to Make Motherhood Safer - 2003-2005 pp. 117-129.
4. Bedard E, Shore DF, Gatzoulis MA, (2008) Adult congenital heart disease: a 2008 overview. Br Med Bull 85: 151-180.
5. Curry R, Swan L, Steer PJ, (2009) Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 21: 508-513.
6. Gelson E, Gatzoulis MA, Steer P, Johnson MR, (2009) Heart disease-why is maternal mortality increasing? BJOG 116: 609-611.
7. Schutte JM, Steegers EA, Schuitemaker NW, Santema JG, de Boer K, et al. (2010) Rise in maternal mortality in the Netherlands. BJOG 117: 399-406.
8. Zwart JJ, Richters JM, Ory F, de Vries JI, Bloemenkamp KW, et al. (2008) Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371,000 pregnancies. BJOG 115: 842-850.
9. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, et al. (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12: 767-778.
10. Palmer CM, Norris MC, Giudici MC, Leighton BL, DeSimone CA, (1990) Incidence of electrocardiographic changes during cesarean delivery under regional anesthesia. Anesth Analg 70: 36-43.
11. Statistics Netherlands (CBS) (2007) Statline, Central Bureau of Statistics. Available at: http://www.cbs.nl/en-GB/. Accessed 2 October 2007.
12. LVR.Landelijke Verloskunde Registratie [Dutch Perinatal Database]: (2011) The Netherlands Perinatal Registry.
13. Kwee A, Bots ML, Visser GH, Bruinse HW, (2007) Obstetric management and outcome of pregnancy in women with a history of caesarean section in the Netherlands. Eur J Obstet Gynecol Reprod Biol 132: 171-176.
14. Dutch Society of Obstetricians and Gynaecologists (NVOG). (2011) Nationwide IVF results 2005. Available at: http://www.nvog.nl/files/landelijkeivfcijfers2005.pdf. Accessed 22 March 2011.
15. Regitz-Zagrosek V, Blomstrom LC, Borghi C, Cifkova R, Ferreira R, et al. (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32: 3147-3197.
16. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, et al. (2012) Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J In press.
17. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, et al. (2007) Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 49: 2303-2311.
18. Balci A, Sollie KM, Mulder BJ, de Laat MW, Roos-Hesselink JW, et al. (2011) Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Am Heart J 161: 269-275.
19. Bonneux L, Zaadstra BM, de Beer JA, (2008) [Sensible family planning: pitfalls and dilemmas]. Ned Tijdschr Geneeskd 152: 2697.
20. Usta IM, Nassar AH, (2008) Advanced maternal age. Part I: obstetric complications. Am J Perinatol 25: 521-534.
21. Callaghan WM, Mackay AP, Berg CJ, (2008) Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol 199: 133-138.
22. Brace V, Penney G, Hall M, (2004) Quantifying severe maternal morbidity: a Scottish population study. BJOG 111: 481-484.
23. Waterstone M, Bewley S, Wolfe C, (2001) Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 322: 1089-1093.
24. Wen SW, Huang L, Liston R, Heaman M, Baskett T, et al. (2005) Severe maternal morbidity in Canada, 1991-2001. CMAJ 173: 759-764.
25. Bax A, Middeldorp AM, Harinck B, Holleboom C, van Roosmalen J, (1999) Unilateral pulmonary edema as a life-threatening complication of ritodrine. Acta Obstet Gynecol Scand 78: 915-916.
26. Chen YC, Chang YM, Yeh GP, Tsai HD, Hsieh CT, (2009) Acute myocardial infarction during pregnancy. Taiwan J Obstet Gynecol 48: 181-185.
27. Fornet I, Calvo M, Gimeno M, Canser E, Alonso E, et al. (2006) [Acute myocardial infarction during tocolytic treatment with ritodrine]. Rev Esp Anestesiol Reanim 53: 312-314.
28. Blickstein I, Zalel Y, Katz Z, Lancet M, (1988) Ritodrine-induced pulmonary edema unmasking underlying peripartum cardiomyopathy. Am J Obstet Gynecol 159: 332-333.
29. Fliers E, Duren DR, van Zwieten PA, (1991) A prostaglandin analogue as a probable cause of myocardial infarction in a young woman. BMJ 302: 416.
30. Stock A, Jones R, Chung T, Fung HY, (1995) Pulmonary edema in association with an intravenous infusion of sulprostone. Acta Obstet Gynecol Scand 74: 156-158.
31. Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, et al. (1992) Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 71: 278-283.
32. Farmacotherapeutisch Kompas (2009) medisch farmaceutische voorlichting/uitgave van de Commissie Farmaceutische Hulp van het College voor zorgverzekeringen. 579-580.
33. Ntusi NB, Mayosi BM, (2009) Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 131: 168-179.
34. la Chapelle CF, Schutte JM, Schuitemaker NW, Steegers EA, van Roosmalen J, (2012) Maternal mortality attributable to vascular dissection and rupture in the Netherlands: a nationwide confidential enquiry. BJOG 119: 86-93.